Annette Fasan

2.4k total citations
34 papers, 1.2k citations indexed

About

Annette Fasan is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Annette Fasan has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 12 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Annette Fasan's work include Acute Myeloid Leukemia Research (23 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Annette Fasan is often cited by papers focused on Acute Myeloid Leukemia Research (23 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers). Annette Fasan collaborates with scholars based in Germany, United States and Sweden. Annette Fasan's co-authors include Torsten Haferlach, Wolfgang Kern, Claudia Haferlach, Susanne Schnittger, Christiane Eder, Alexander Kohlmann, Vera Grossmann, Tamara Alpermann, Manja Meggendorfer and Sandra Weißmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Annette Fasan

32 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annette Fasan Germany 14 676 646 299 258 188 34 1.2k
Claire L. Green United Kingdom 5 504 0.7× 359 0.6× 296 1.0× 223 0.9× 148 0.8× 6 819
Eveline J. Kamping Netherlands 14 378 0.6× 610 0.9× 252 0.8× 229 0.9× 188 1.0× 23 1.2k
Sam Agresta United States 15 442 0.7× 474 0.7× 285 1.0× 315 1.2× 127 0.7× 27 912
Katherine Waghorn United Kingdom 10 660 1.0× 730 1.1× 500 1.7× 115 0.4× 75 0.4× 13 1.2k
Ashwin Kishtagari United States 11 564 0.8× 305 0.5× 323 1.1× 221 0.9× 60 0.3× 56 857
Ruth Knops Netherlands 6 705 1.0× 902 1.4× 283 0.9× 171 0.7× 52 0.3× 12 1.2k
Heather K. Schmidt United States 8 857 1.3× 625 1.0× 460 1.5× 402 1.6× 83 0.4× 14 1.4k
Dong‐ming Yao China 20 684 1.0× 786 1.2× 201 0.7× 315 1.2× 59 0.3× 61 1.0k
Yue-Zhong Wu United States 7 770 1.1× 670 1.0× 311 1.0× 396 1.5× 48 0.3× 16 1.1k
Zhaohui Gu United States 15 808 1.2× 855 1.3× 272 0.9× 262 1.0× 45 0.2× 36 1.4k

Countries citing papers authored by Annette Fasan

Since Specialization
Citations

This map shows the geographic impact of Annette Fasan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Fasan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Fasan more than expected).

Fields of papers citing papers by Annette Fasan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Fasan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Fasan. The network helps show where Annette Fasan may publish in the future.

Co-authorship network of co-authors of Annette Fasan

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Fasan. A scholar is included among the top collaborators of Annette Fasan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Fasan. Annette Fasan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kisser, Agnes, et al.. (2021). Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective. The European Journal of Health Economics. 23(5). 863–878. 4 indexed citations
2.
Höllein, Alexander, Sabine Jeromin, Manja Meggendorfer, et al.. (2018). Minimal residual disease (MRD) monitoring and mutational landscape in AML with RUNX1-RUNX1T1: a study on 134 patients. Leukemia. 32(10). 2270–2274. 17 indexed citations
3.
4.
Stengel, Anna, Manja Meggendorfer, Annette Fasan, et al.. (2017). Impact of 9q Deletions on the Classification in AML. Blood. 130. 3925–3925. 2 indexed citations
5.
Fasan, Annette, Claudia Haferlach, Karolína Perglerová, Wolfgang Kern, & Torsten Haferlach. (2016). CSF3R Mutations Are Predominantly Subclonal Events in Intermediate Risk Karyotype AML and Prevalently Occur with CEBPA Mutations. Blood. 128(22). 1658–1658. 1 indexed citations
6.
Stengel, Anna, Wolfgang Kern, Torsten Haferlach, et al.. (2016). The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases. Leukemia. 31(3). 705–711. 148 indexed citations
7.
Alpermann, Tamara, Claudia Haferlach, Annette Fasan, et al.. (2015). Prognosis of Mecom(EVI1)- rearranged MDS and AML Patients Strongly Depends on Accompanying Molecular Mutations but Not on Blast Counts. Blood. 126(23). 1372–1372. 3 indexed citations
8.
Fasan, Annette, Claudia Haferlach, Christiane Eder, et al.. (2015). Evaluation of IDH1G105 polymorphism as prognostic marker in intermediate-risk AML. Annals of Hematology. 94(12). 1991–2001. 2 indexed citations
9.
Alpermann, Tamara, Frank Dicker, Sabine Jeromin, et al.. (2014). BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia. Blood Cancer Journal. 4(1). e173–e173. 33 indexed citations
10.
Fasan, Annette, Claudia Haferlach, Tamara Alpermann, et al.. (2013). The role of different genetic subtypes of CEBPA mutated AML. Leukemia. 28(4). 794–803. 116 indexed citations
11.
Schnittger, Susanne, Niroshan Nadarajah, Tamara Alpermann, et al.. (2013). Comparison Of Mutation Patterns Between Diagnosis and Relapse In 556 Adult Patients With AML Shows High Variability Of Stability. Blood. 122(21). 4978–4978. 1 indexed citations
12.
Richter, Günther, Annette Fasan, Thomas G. P. Grünewald, et al.. (2013). G‐Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1. The Journal of Pathology. 230(1). 70–81. 48 indexed citations
13.
Schnittger, Susanne, Tamara Alpermann, Niroshan Nadarajah, et al.. (2012). Comparison of Mutation Patterns Between Diagnosis and Relapse in 444 Patients with Acute Myeloid Leukemia Shows High Variability of Stability and Influence On Time to Relapse. Blood. 120(21). 408–408. 1 indexed citations
14.
Großmann, Vera, Susanne Schnittger, Alexander Kohlmann, et al.. (2012). High Incidence of RAS Signalling Pathway Mutations in MLL–rearranged Acute Myeloid Leukemia. Blood. 120(21). 539–539. 1 indexed citations
15.
Schnittger, Susanne, Christiane Eder, Sabine Jeromin, et al.. (2012). ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome. Leukemia. 27(1). 82–91. 153 indexed citations
16.
Fasan, Annette, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, & Susanne Schnittger. (2012). STAT3 Mutations in Large Granular Lymphocytic Leukemia. Blood. 120(21). 1606–1606. 2 indexed citations
17.
Schnittger, Susanne, Christiane Eder, Tamara Alpermann, et al.. (2011). ASXL1 exon 12 Mutations Are Frequent in AML with Intermediate Risk Karyotype and Are Independently Associated with An Extremely Poor Outcome. Blood. 118(21). 416–416. 5 indexed citations
18.
Weißmann, Sandra, Tamara Alpermann, Vera Grossmann, et al.. (2011). Landscape of TET2 mutations in acute myeloid leukemia. Leukemia. 26(5). 934–942. 183 indexed citations
19.
Hüser, Norbert, et al.. (2009). Intact LFA-1 deactivation promotes T-cell activation and rejection of cardiac allograft. International Immunology. 22(1). 35–44. 2 indexed citations
20.
Geinitz, Hans, Herbert Braselmann, Adolf Baumgartner, et al.. (2005). Time-course of radiation-induced chromosomal aberrations in tumor patients after radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 63(4). 1214–1220. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire L. Green Breakdown of academic impact, for papers by Eveline J. Kamping Breakdown of academic impact, for papers by Sam Agresta Breakdown of academic impact, for papers by Katherine Waghorn Breakdown of academic impact, for papers by Ashwin Kishtagari Breakdown of academic impact, for papers by Ruth Knops Breakdown of academic impact, for papers by Heather K. Schmidt Breakdown of academic impact, for papers by Dong‐ming Yao Breakdown of academic impact, for papers by Yue-Zhong Wu Breakdown of academic impact, for papers by Zhaohui Gu
Rankless by CCL
2026